Citigroup’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-22,200
| Closed | -$1.66M | – | 5648 |
|
|
2022
Q4 | $1.66M | Buy |
+22,200
| New | +$1.58M | ﹤0.01% | 2191 |
|
|
2022
Q2 | – | Sell |
-78,300
| Closed | -$6.01M | – | 6403 |
|
|
2022
Q1 | $6.01M | Buy |
+78,300
| New | +$5.63M | ﹤0.01% | 1572 |
|
|
2021
Q1 | – | Sell |
-4,100
| Closed | -$299K | – | 6750 |
|
|
2020
Q4 | $299K | Sell |
4,100
-9,300
| -69% | -$656K | ﹤0.01% | 4662 |
|
|
2020
Q3 | $891K | Sell |
13,400
-11,300
| -46% | -$715K | ﹤0.01% | 3381 |
|
|
2020
Q2 | $1.41M | Sell |
24,700
-11,400
| -32% | -$559K | ﹤0.01% | 3184 |
|
|
2020
Q1 | $1.27M | Sell |
36,100
-94,400
| -72% | -$4.49M | ﹤0.01% | 2928 |
|
|
2019
Q4 | $6.81M | Buy |
130,500
+54,700
| +72% | +$2.72M | ﹤0.01% | 1771 |
|
|
2019
Q3 | $3.83M | Buy |
75,800
+56,600
| +295% | +$2.79M | ﹤0.01% | 2182 |
|
|
2019
Q2 | $922K | Sell |
19,200
-6,500
| -25% | -$301K | ﹤0.01% | 3726 |
|
|
2019
Q1 | $1.24M | Sell |
25,700
-63,200
| -71% | -$2.85M | ﹤0.01% | 3170 |
|
|
2018
Q4 | $3.65M | Buy |
88,900
+200
| +0.2% | +$8.2K | ﹤0.01% | 2114 |
|
|
2018
Q3 | $3.63M | Sell |
88,700
-1,500
| -2% | -$60.6K | ﹤0.01% | 2167 |
|
|
2018
Q2 | $3.58M | Buy |
90,200
+32,300
| +56% | +$1.24M | ﹤0.01% | 2149 |
|
|
2018
Q1 | $2.16M | Buy |
57,900
+3,000
| +5% | +$121K | ﹤0.01% | 2522 |
|
|
2017
Q4 | $2.35M | Buy |
54,900
+25,400
| +86% | +$1.01M | ﹤0.01% | 2511 |
|
|
2017
Q3 | $1.08M | Sell |
29,500
-114,100
| -79% | -$4.61M | ﹤0.01% | 3278 |
|
|
2017
Q2 | $6.52M | Buy |
143,600
+102,800
| +252% | +$4.54M | 0.01% | 1475 |
|
|
2017
Q1 | $1.74M | Sell |
40,800
-5,600
| -12% | -$228K | ﹤0.01% | 2626 |
|
|
2016
Q4 | $1.86M | Buy |
46,400
+26,400
| +132% | +$1.02M | ﹤0.01% | 3035 |
|
|
2016
Q3 | $777K | Sell |
20,000
-13,800
| -41% | -$521K | ﹤0.01% | 3481 |
|
|
2016
Q2 | $1.17M | Buy |
33,800
+17,500
| +107% | +$606K | ﹤0.01% | 2802 |
|
|
2016
Q1 | $562K | Sell |
16,300
-3,200
| -16% | -$112K | ﹤0.01% | 3999 |
|
|
2015
Q4 | $754K | Sell |
19,500
-40,000
| -67% | -$1.56M | ﹤0.01% | 3433 |
|
|
2015
Q3 | $2.33M | Sell |
59,500
-24,600
| -29% | -$976K | ﹤0.01% | 2315 |
|
|
2015
Q2 | $3.2M | Buy |
84,100
+15,600
| +23% | +$546K | ﹤0.01% | 2135 |
|
|
2015
Q1 | $2.26M | Buy |
68,500
+1,100
| +2% | +$33.8K | ﹤0.01% | 2372 |
|
|
2014
Q4 | $1.8M | Sell |
67,400
-17,600
| -21% | -$454K | ﹤0.01% | 2553 |
|
|
2014
Q3 | $2.07M | Buy |
85,000
+58,300
| +218% | +$1.47M | ﹤0.01% | 2523 |
|
|
2014
Q2 | $677K | Buy |
26,700
+15,300
| +134% | +$358K | ﹤0.01% | 3250 |
|
|
2014
Q1 | $245K | Sell |
11,400
-70,100
| -86% | -$1.51M | ﹤0.01% | 4136 |
|
|
2013
Q4 | $1.82M | Buy |
81,500
+59,100
| +264% | +$1.3M | ﹤0.01% | 2658 |
|
|
2013
Q3 | $463K | Sell |
22,400
-436,200
| -95% | -$9.29M | ﹤0.01% | 3494 |
|
|
2013
Q2 | $8.85M | Buy |
+458,600
| New | +$9.58M | 0.01% | 1165 |
|
Other funds holding HOLX
VCM
HI
VPM
Citigroup's HOLX Position: Q1 2026 in Review
Citigroup increased its Hologic (HOLX) stake by 36% in Q1 2026, buying an estimated $10.7M and bringing the position to 537,511 shares worth $40.6M. The position accounts for 0.02% of the portfolio, ranked #725.
Citigroup first reported a position in HOLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $85.2M in Q2 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.
- Citigroup held 537,511 shares of Hologic worth $40.6M as of Q1 2026.
- Citigroup bought 142,582 Hologic shares in Q1 2026, an estimated $10.7M.
- Hologic made up 0.02% of Citigroup's portfolio in Q1 2026, its #725 holding.
- Citigroup first reported a position in Hologic in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Hologic position peaked at $85.2M in Q2 2025.
- 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.